Foghorn Therapeutics (FHTX) Short Interest Ratio & Short Volume $5.16 +0.21 (+4.24%) As of 07/3/2025 01:04 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Foghorn Therapeutics Short Interest DataFoghorn Therapeutics (FHTX) has a short interest of 1.47 million shares, representing 5.27% of the float (the number of shares available for trading by the public). This marks a 33.64% increase in short interest from the previous month. The short interest ratio (days to cover) is 11.9, indicating that it would take 11.9 days of the average trading volume of 143,124 shares to cover all short positions.Current Short Interest1,470,000 sharesPrevious Short Interest1,100,000 sharesChange Vs. Previous Month+33.64%Dollar Volume Sold Short$6.35 millionShort Interest Ratio11.9 Days to CoverLast Record DateJune 15, 2025Outstanding Shares55,740,000 sharesFloat Size27,900,000 sharesShort Percent of Float5.27%Today's Trading Volume80,445 sharesAverage Trading Volume143,124 sharesToday's Volume Vs. Average56% Short Selling Foghorn Therapeutics? Sign up to receive the latest short interest report for Foghorn Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartFHTX Short Interest Over TimeFHTX Days to Cover Over TimeFHTX Percentage of Float Shorted Over Time Foghorn Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/20251,470,000 shares $6.35 million +33.6%5.3%11.9 $4.32 5/31/20251,100,000 shares $4.55 million +2.8%3.9%8.9 $4.14 5/15/20251,070,000 shares $4.61 million +0.9%3.8%8.9 $4.31 4/30/20251,060,000 shares $4.45 million -0.9%3.8%7.6 $4.20 4/15/20251,070,000 shares $3.82 million +7.5%3.8%7.9 $3.57 3/31/2025995,700 shares $3.63 million +2.1%3.6%7.1 $3.65 3/15/2025975,700 shares $4.32 million -3.4%3.5%6.8 $4.43 2/28/20251,010,000 shares $4.90 million +4.6%3.6%6.2 $4.85 2/15/2025965,300 shares $5.92 million +5.2%3.5%5.9 $6.13 1/31/2025918,000 shares $3.85 million +9.1%3.5%5.7 $4.19 Get the Latest News and Ratings for FHTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Foghorn Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/2025841,700 shares $3.66 million +8.4%3.0%5.6 $4.35 12/31/2024776,800 shares $3.67 million -18.1%2.8%5.1 $4.72 12/15/2024948,600 shares $5.03 million +6.8%3.4%6.3 $5.30 11/30/2024888,000 shares $7.10 million -9.7%3.2%5.7 $7.99 11/15/2024983,500 shares $7.88 million -13.0%3.5%6.2 $8.01 10/31/20241,130,000 shares $8.61 million -15.0%3.9%6.9 $7.62 10/15/20241,330,000 shares $10.16 million +10.8%4.7%8.5 $7.64 9/30/20241,200,000 shares $11.17 million +9.1%4.2%7.9 $9.31 9/15/20241,100,000 shares $10.69 million +3.8%3.9%7 $9.72 8/31/20241,060,000 shares $8.78 million +65.0%3.7%8.7 $8.28 8/15/2024642,400 shares $3.98 million -46.5%2.2%5.4 $6.20 7/31/20241,200,000 shares $8.42 million -4.8%3.8%11.1 $7.02 7/15/20241,260,000 shares $7.88 million +15.6%4.0%12.2 $6.25 6/30/20241,090,000 shares $6.27 million +10.6%3.5%10.6 $5.75 6/15/2024985,300 shares $5.17 million -23.0%3.1%11.5 $5.25 5/31/20241,280,000 shares $7.46 million -1.5%5.3%14.9 $5.83 5/15/20241,300,000 shares $6.88 million -1.5%5.4%14.1 $5.29 4/30/20241,320,000 shares $7.21 million +11.9%7.1%9.6 $5.46 4/15/20241,180,000 shares $7.54 million -0.8%6.3%7.4 $6.39 3/31/20241,190,000 shares $7.98 million -4.8%6.4%7.4 $6.71 3/15/20241,250,000 shares $7.39 million No Change6.8%7.7 $5.91 2/29/20241,250,000 shares $9.66 million -8.8%6.8%7.5 $7.73 2/15/20241,370,000 shares $9.33 million +29.3%7.5%8.7 $6.81 1/31/20241,060,000 shares $3.37 million +16.2%6.0%7.7 $3.18 1/15/2024912,600 shares $4.80 million -0.2%5.2%9.5 $5.26 12/31/2023914,200 shares $5.90 million -8.0%5.2%9.2 $6.45 12/15/2023994,100 shares $5.26 million -3.5%5.7%9.4 $5.29 11/30/20231,030,000 shares $4.38 million -1.0%5.9%10.4 $4.25 11/15/20231,040,000 shares $4.17 million -23.5%6.0%10.3 $4.01 10/31/20231,360,000 shares $4.56 million +17.2%7.8%14.7 $3.35Here's the last trade you should make before heading out for the weekend tomorrow. (Ad)Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Give me the details 10/15/20231,160,000 shares $4.05 million -28.8%6.7%13.9 $3.49 9/30/20231,630,000 shares $8.15 million -2.4%9.5%20.9 $5.00 9/15/20231,670,000 shares $10.87 million -5.1%9.7%25.5 $6.51 8/31/20231,760,000 shares $13.32 million -15.4%9.8%23.6 $7.57 8/15/20232,080,000 shares $20.53 million No Change11.6%28.6 $9.87 7/31/20232,080,000 shares $19.05 million -3.3%11.8%24.7 $9.16 7/15/20232,150,000 shares $16.77 million +1.4%12.4%23.1 $7.80 6/30/20232,120,000 shares $14.92 million +1.0%12.1%21.5 $7.04 6/15/20232,100,000 shares $17.87 million -0.9%12.0%22.3 $8.51 5/31/20232,120,000 shares $13.33 million -0.9%12.1%24.7 $6.29 5/15/20232,140,000 shares $13.80 million +3.9%12.2%26.7 $6.45 4/30/20232,060,000 shares $13.43 million No Change11.7%27.4 $6.52 4/15/20232,060,000 shares $14.75 million -5.9%11.7%30.7 $7.16 3/31/20232,190,000 shares $13.58 million +3.3%12.5%32.1 $6.20 3/15/20232,120,000 shares $10.41 million +3.9%12.1%31 $4.91 2/28/20232,040,000 shares $11.69 million +3.6%11.6%27.3 $5.73 2/15/20231,970,000 shares $12.27 million +5.9%11.2%24.5 $6.23 1/31/20231,860,000 shares $16.00 million +0.5%10.6%21.8 $8.60 1/15/20231,850,000 shares $16.11 million -2.1%10.6%20.9 $8.71 12/30/20221,890,000 shares $12.06 million +3.3%10.8%23.7 $6.38 12/15/20221,830,000 shares $11.75 million +0.6%10.4%22.9 $6.42 11/30/20221,820,000 shares $12.29 million -6.7%10.4%23.2 $6.75 11/15/20221,950,000 shares $18.00 million -22.6%11.2%24.3 $9.23 10/31/20222,520,000 shares $22.02 million +2.4%14.1%26.9 $8.74 10/15/20222,460,000 shares $18.23 million -0.8%13.8%25.9 $7.41 9/30/20222,480,000 shares $21.28 million +0.8%13.9%25.5 $8.58 9/15/20222,460,000 shares $24.43 million +2.1%13.8%23.6 $9.93 8/31/20222,410,000 shares $23.96 million -11.4%13.5%21.7 $9.94 8/15/20222,720,000 shares $45.59 million -4.2%15.2%21.2 $16.76 7/31/20222,840,000 shares $41.55 million -3.7%16.0%19.8 $14.63 7/15/20222,950,000 shares $45.28 million -1.0%16.6%20.6 $15.35 6/30/20222,980,000 shares $40.53 million -0.3%16.8%20.5 $13.60 6/15/20222,990,000 shares $36.75 million +4.2%16.8%19.6 $12.29 5/31/20222,870,000 shares $37.02 million +6.3%16.1%17.5 $12.90 5/15/20222,700,000 shares $27.68 million +38.5%15.1%15.2 $10.25 4/30/20221,950,000 shares $22.60 million -2.0%10.9%13.6 $11.59 4/15/20221,990,000 shares $29.01 million +0.5%11.2%14.2 $14.58 3/31/20221,980,000 shares $30.16 million +3.7%N/A12.7 $15.23 3/15/20221,910,000 shares $21.41 million +76.9%10.7%10.3 $11.21 2/28/20221,080,000 shares $10.38 million +21.6%7.2%1.8 $9.61 2/15/2022888,500 shares $11.11 million +10.8%5.9%1.6 $12.50 1/31/2022802,000 shares $12.33 million -11.3%5.9%1.4 $15.38 1/15/2022904,200 shares $15.92 million -13.1%N/A0 $17.61 12/31/20211,040,000 shares $23.78 million -24.6%7.7%1.9 $22.87 12/15/20211,380,000 shares $24.26 million +97.5%10.2%2.7 $17.58 11/30/2021698,600 shares $8.08 million +2.8%4.1%11.4 $11.57 11/15/2021679,800 shares $9.27 million -10.7%4.0%10.2 $13.63 10/29/2021760,900 shares $9.66 million -10.9%4.5%10.9 $12.69 10/15/2021853,600 shares $10.57 million -1.1%5.0%12.1 $12.38 9/30/2021863,100 shares $12.02 million -1.7%5.1%12.4 $13.93Here's the last trade you should make before heading out for the weekend tomorrow. (Ad)Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Give me the details 9/15/2021877,600 shares $11.16 million -3.9%5.1%8.4 $12.72 8/31/2021912,800 shares $11.85 million -6.6%5.4%7.8 $12.98 8/13/2021977,400 shares $9.34 million +3.9%5.7%8.5 $9.56 7/30/2021941,100 shares $8.54 million -0.8%5.5%7.9 $9.07 7/15/2021948,900 shares $8.96 million -1.5%5.6%7.9 $9.44 6/30/2021963,600 shares $10.28 million +17.0%5.7%7.9 $10.67 6/15/2021823,500 shares $9.87 million +11.6%4.8%9.1 $11.99 5/28/2021737,700 shares $7.68 million -1.4%4.3%8.1 $10.41 5/14/2021748,300 shares $7.48 million +2.8%4.4%8.7 $9.99 4/30/2021727,800 shares $7.73 million -1.3%4.3%8.6 $10.62 4/15/2021737,300 shares $8.80 million -0.6%N/A0 $11.94 3/31/2021741,800 shares $9.66 million +24.3%4.3%7.1 $13.02 3/15/2021596,800 shares $7.49 million +5.4%3.6%4.7 $12.55 2/26/2021566,400 shares $9.23 million +9.8%3.5%4.8 $16.30 2/12/2021515,800 shares $8.82 million +25.0%3.2%4 $17.09 1/29/2021412,500 shares $6.86 million +43.2%2.6%2.9 $16.63 1/15/2021288,100 shares $5.47 million No Change1.8%1.4 $18.98 FHTX Short Interest - Frequently Asked Questions What is Foghorn Therapeutics' current short interest? Short interest is the volume of Foghorn Therapeutics shares that have been sold short but have not yet been closed out or covered. As of June 15th, investors have sold 1,470,000 shares of FHTX short. 5.27% of Foghorn Therapeutics' shares are currently sold short. Learn More on Foghorn Therapeutics' current short interest. What is a good short interest ratio for Foghorn Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. FHTX shares currently have a short interest ratio of 12.0. Learn More on Foghorn Therapeutics's short interest ratio. Which institutional investors are shorting Foghorn Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Foghorn Therapeutics: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Foghorn Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.27% of Foghorn Therapeutics' floating shares are currently sold short. Is Foghorn Therapeutics' short interest increasing or decreasing? Foghorn Therapeutics saw a increase in short interest in the month of June. As of June 15th, there was short interest totaling 1,470,000 shares, an increase of 33.6% from the previous total of 1,100,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Foghorn Therapeutics' float size? Foghorn Therapeutics currently has issued a total of 55,740,000 shares. Some of Foghorn Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Foghorn Therapeutics currently has a public float of 27,900,000 shares. How does Foghorn Therapeutics' short interest compare to its competitors? 5.27% of Foghorn Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Foghorn Therapeutics: AbCellera Biologics Inc. (11.84%), Phibro Animal Health Corporation (4.91%), WAVE Life Sciences Ltd. (13.49%), Enliven Therapeutics, Inc. (17.08%), Verve Therapeutics, Inc. (27.37%), Intellia Therapeutics, Inc. (29.58%), Collegium Pharmaceutical, Inc. (15.65%), Akebia Therapeutics, Inc. (7.26%), Spyre Therapeutics, Inc. (24.53%), Mineralys Therapeutics, Inc. (15.19%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks. What does it mean to sell short Foghorn Therapeutics stock? Short selling FHTX is an investing strategy that aims to generate trading profit from Foghorn Therapeutics as its price is falling. FHTX shares are trading up $0.21 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Foghorn Therapeutics? A short squeeze for Foghorn Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of FHTX, which in turn drives the price of the stock up even further. How often is Foghorn Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FHTX, twice per month. The most recent reporting period available is June, 15 2025. More Short Interest Resources from MarketBeat Related Companies AbCellera Biologics Short Interest Data Phibro Animal Health Short Interest Data WAVE Life Sciences Short Interest Data Enliven Therapeutics Short Interest Data Verve Therapeutics Short Interest Data Intellia Therapeutics Short Interest Data Collegium Pharmaceutical Short Interest Data Akebia Therapeutics Short Interest Data Spyre Therapeutics Short Interest Data Mineralys Therapeutics Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:FHTX) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Foghorn Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Foghorn Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
